Entrotech Life Sciences

Entrotech Life Sciences is a medical technology company specializing in advanced materials science to prevent healthcare-associated infections (HAIs). The company developed the ChloraSure platform, which utilizes a non-leaching chlorhexidine gluconate (CHG) technology integrated into surgical incise films and vascular access dressings to provide continuous antimicrobial protection. Their products, such as PrevaCheck, provide visual confirmation of skin antisepsis to improve clinical outcomes and patient safety. By focusing on the intersection of chemistry and medicine, Entrotech creates solutions that offer antimicrobial efficacy without the risks associated with traditional leaching agents. In early 2023, the company was acquired by Avery Dennison to bolster its medical adhesive and skin-contact product portfolio.